摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-chloro-5-(5-chlorothiophen-2-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine

中文名称
——
中文别名
——
英文名称
3-chloro-5-(5-chlorothiophen-2-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine
英文别名
——
3-chloro-5-(5-chlorothiophen-2-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine化学式
CAS
——
化学式
C15H7Cl2F3N2S
mdl
——
分子量
375.201
InChiKey
MHXATPJHYVMMEM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.4
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    54
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

点击查看最新优质反应信息

文献信息

  • NOVEL PYRIDAZINE DERIVATIVES
    申请人:Trah Stephan
    公开号:US20100113464A1
    公开(公告)日:2010-05-06
    The present invention relates to novel pyridazine derivatives of formula I as active ingredients which have microbiocidal activity, in particular fungicidal activity: wherein R 1 is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl or C 3 -C 6 cycloalkyl; R 2 is an optionally substituted heteroaryl; R 3 is an optionally substituted aryl; and R 4 is hydrogen, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, (VCehaloalkoxy, hydroxy or cyano; or an agrochemically usable salt form thereof.
    本发明涉及一种新的吡嗪衍生物,其化学式为I,作为活性成分具有微生物杀菌活性,特别是真菌杀菌活性:其中R1为氢,C1-C6烷基,C1-C6卤代烷基或C3-C6环烷基;R2为可选取代的杂环芳基;R3为可选取代的芳基;R4为氢,卤素,C1-C6烷基,C1-C6卤代烷基,C1-C6烷氧基,(VCe卤代烷氧基,羟基或氰基;或其农药可用盐形式。
  • HETEROCYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF NEURODEGENERATIVE TAUOPATHIES
    申请人:THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    公开号:US20150224105A1
    公开(公告)日:2015-08-13
    The present invention is directed to triazolopyrimidine, phenylpyrimidine, pyridopyridazine, and pyridotriazine compounds which are microtubule-stabilizing compounds and their use in the treatment of neurodegenerative disorders, in particular, tauopathies, such as for example, Alzheimer's disease, frontotemporal lobar degeneration, Pick's disease, progressive supranuclear palsy (PSP), and corticobasal degeneration. In addition, the compounds of the invention may be useful for other diseases where tau pathology is a comorbidity or where microtubule function is compromised, for example, schizophrenia, Parkinson's disease (PD), PD with dementia, Lewy body disease with dementia, and amyotrophic lateral sclerosis.
    本发明涉及三唑并嘧啶、苯基嘧啶、吡啶并吡嗪和吡啶并三嗪类化合物,它们是微管稳定剂化合物,以及它们在治疗神经退行性疾病中的应用,特别是tau病理学,例如阿尔茨海默病、额颞叶变性、皮克氏病、进展性上皮核瘤和皮质基底节变性。此外,本发明中的化合物也可能对其他tau病理学是共病或微管功能受损的疾病有用,例如精神分裂症、帕金森病(PD)、带有痴呆的PD、带有痴呆的Lewy体病和肌萎缩侧索硬化症。
  • US9649317B2
    申请人:——
    公开号:US9649317B2
    公开(公告)日:2017-05-16
  • [EN] NOVEL PYRIDAZINE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS DE PYRIDAZINE
    申请人:SYNGENTA PARTICIPATIONS AG
    公开号:WO2008009406A1
    公开(公告)日:2008-01-24
    [EN] The present invention relates to novel pyridazine derivatives of formula I as active ingredients which have microbiocidal activity, in particular fungicidal activity: wherein R1 is hydrogen, C1-C6alkyl, C1-C6haloalkyl or C3-C6cycloalkyl; R2 is an optionally substituted heteroaryl; R3 is an optionally substituted aryl; and R4 is hydrogen, halogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, (VCehaloalkoxy, hydroxy or cyano; or an agrochemically usable salt form thereof.
    [FR] La présente invention concerne de nouveaux dérivés de pyridazine représentés par la formule I, en tant qu'ingrédients actifs qui ont une activité microbiocide, en particulier une activité fongicide : où R1 représente l'hydrogène, l'alkyle en C1-C6, l'haloalkyle en C1-C6 ou le cycloalkyle en C3-C6; R2 représente un hétéroaryle facultativement substitué; R3 représente un aryle facultativement substitué; et R4 représente l'hydrogène, l'halogène, l'alkyle en C1-C6, l'haloalkyle en C1-C6, l'alcoxy en C1-C6, l'haloalcoxy, l'hydroxy ou le cyano. L'invention concerne également une forme saline de ces nouveaux dérivés utilisable en agrochimie.
  • [EN] HETEROCYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF NEURODEGENERATIVE TAUOPATHIES<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET LEUR UTILISATION POUR LE TRAITEMENT DE TAUOPATHIES NEURODÉGÉNÉRATIVES
    申请人:UNIV PENNSYLVANIA
    公开号:WO2014047257A2
    公开(公告)日:2014-03-27
    The present invention is directed to triazolopyrimidine, phenylpyrimidine, pyridopyridazine, and pyridotriazine compounds and their use in the treatment of neurodegenerative disorders.
查看更多